Problem statement: Answer the MCQ question.
Question: Which drug exhibits a 16.012\% human ether-à-go-go related gene (hERG) inhibition at 1uM?
Constraint: You must select none, one or more options from a or b without using any additional words.
Options:
(a) CCN(CC)CCCNC(=O)C1CCC(=O)N(c2ccc(OC)cc2)C1c1ccc(F)cc1
(b) CCc1nccn1CCC(=O)NC1CCCc2c1cnn2-c1ccc(F)cc1F
Answer: b. CCc1nccn1CCC(=O)NC1CCCc2c1cnn2-c1ccc(F)cc1F
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_1uM#}{herg_central_at_1uM__units} {herg_central_at_1uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_1uM%}
Answer: {%multiple_choice_result}. {SMILES#}
CCc1nccn1CCC(=O)NC1CCCc2c1cnn2-c1ccc(F)cc1F
CCc1nccn1CCC(=O)NC1CCCc2c1cnn2-c1ccc(F)cc1F
N-[1-(2,4-difluorophenyl)-4,5,6,7-tetrahydroindazol-4-yl]-3-(2-ethylimidazol-1-yl)propanamide